Dr. Aaron Rosenberg
Claim this profileUniversity of California Davis Comprehensive Cancer Center
Area of expertise
Multiple Myeloma
Aaron Rosenberg has run 10 trials for Multiple Myeloma. Some of their research focus areas include:
Plasma Cell Neoplasms
Aaron Rosenberg has run 1 trial for Plasma Cell Neoplasms.
Affiliated Hospitals
University Of California Davis Comprehensive Cancer Center
University Of California Davis (UC Davis) Comprehensive Cancer Center
Clinical Trials Aaron Rosenberg is currently running
Iberdomide
for Multiple Myeloma
This phase II trial compares iberdomide maintenance therapy to disease monitoring for improving survival in patients who have received idecabtagene vicleucel (a type of chimeric antigen receptor T-cell \[CAR-T\] therapy) for multiple myeloma. The usual approach after treatment with idecabtagene vicleucel is to monitor the multiple myeloma without giving myeloma medications. There is currently no medication approved specifically for use after idecabtagene vicleucel treatment. Upon administration, iberdomide modifies the immune system and activates immune cells called T-cells, which could enhance the effectiveness of idecabtagene vicleucel. Iberdomide may keep multiple myeloma under control for longer than the usual approach (disease monitoring) after idecabtagene vicleucel, and may help multiple myeloma patients live longer.
Recruiting
1 award
Phase 2
10 criteria
Ide-cel + Lenalidomide
for Multiple Myeloma
The purpose of this study is to compare the efficacy, safety, and tolerability of ide-cel with lenalidomide (LEN) maintenance to that of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response post autologous stem cell transplantation (ASCT).
Recruiting
2 awards
Phase 3
1 criteria
More about Aaron Rosenberg
Clinical Trial Related
1 year of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Aaron Rosenberg has experience with
- Lenalidomide
- Dexamethasone
- Idecabtagene Vicleucel
- Fludarabine
- Cyclophosphamide
- Daratumumab And Hyaluronidase-fihj
Breakdown of trials Aaron Rosenberg has run
Multiple Myeloma
Plasma Cell Neoplasms
Blood Cancers
Plasmacytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aaron Rosenberg specialize in?
Aaron Rosenberg focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved TP53 positive patients, or patients who are TP53 negative.
Is Aaron Rosenberg currently recruiting for clinical trials?
Yes, Aaron Rosenberg is currently recruiting for 4 clinical trials in Sacramento California. If you're interested in participating, you should apply.
Are there any treatments that Aaron Rosenberg has studied deeply?
Yes, Aaron Rosenberg has studied treatments such as Lenalidomide, Dexamethasone, Idecabtagene Vicleucel.
What is the best way to schedule an appointment with Aaron Rosenberg?
Apply for one of the trials that Aaron Rosenberg is conducting.
What is the office address of Aaron Rosenberg?
The office of Aaron Rosenberg is located at: University of California Davis Comprehensive Cancer Center, Sacramento, California 95817 United States. This is the address for their practice at the University of California Davis Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.